Seong Bok Jang Selected Research

YH4808

1/2022

A population PK-PD model of YH4808, a novel P-CAB, and intragastric pH that incorporated negative feedback by increased intragastric pH onto the systemic exposure to YH4808.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Seong Bok Jang Research Topics

Disease

4	Dyslipidemias (Dyslipidemia) 10/2015 - 08/2014
3	Hypertension (High Blood Pressure) 10/2015 - 08/2014
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 10/2022
1	Gastroesophageal Reflux (GERD) 01/2022
1	Peptic Ulcer (Peptic Ulcers) 01/2022
1	Heart Failure 10/2021
1	Constipation 01/2021
1	Type 2 Diabetes Mellitus (MODY) 08/2014
1	Hypercholesterolemia 08/2014
1	Pain (Aches) 08/2014
1	Cough 08/2014
1	Obesity 01/2011

Drug/Important Bio-Agent (IBA)

4	Rosuvastatin Calcium (Crestor)FDA Link 10/2015 - 08/2014
2	lazertinibIBA 01/2023 - 10/2022
2	AcidsIBA 10/2022 - 01/2022
2	Telmisartan (Micardis)FDA Link 10/2015 - 08/2014
2	Angiotensin Receptor AntagonistsIBA 01/2015 - 08/2014
1	Tyrosine Kinase InhibitorsIBA 01/2023
1	ErbB Receptors (EGF Receptor)IBA 01/2023
1	Reducing AgentsIBA 10/2022
1	YH4808IBA 01/2022
1	PotassiumIBA 01/2022
1	Serotonin (5 Hydroxytryptamine)IBA 01/2021
1	YH12852IBA 01/2021
1	LipidsIBA 10/2015
1	Antihypertensive Agents (Antihypertensives)IBA 10/2015
1	Valsartan (Vals)FDA Link 01/2015
1	Oxidoreductases (Dehydrogenase)IBA 01/2015
1	Coenzyme A (CoA)IBA 01/2015
1	Metformin (Glucophage)FDA LinkGeneric 08/2014
1	3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA)IBA 08/2014
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 08/2014
1	sibutramine (Meridia)FDA Link 01/2011

Therapy/Procedure

2	Therapeutics 10/2021 - 08/2014